This study reveals a much larger issue: how incentive structures in our healthcare system often prevent patients from receiving the best careespecially when that care is simple, effective, and inexpensive
2 Improved blood pressure and cholesterol Some people taking GLP-1 agonists find that their blood pressure and/or cholesterol levels improve
Clinical Trial Status Cagrilintide has completed Phase 3 clinical trials (the REDEFINE program) by Novo Nordisk
When a meal is expanded, GLP-1 gets released and stimulates the secretion of insulin, which inhibits glucagon release and gastric emptying slowly
An ideal experiment would likely be to start the mice in any one of the protection cells in the table on a high fat diet with no drug, then give them the protection drug midway through the trial while keeping them on a high fat diet, and see if they lose weight or maintain their obesity
Anyone promising that is either uninformed or dishonest